Clinical Trial: An Extension Trial of GW 906 in Participants With Essential Hypertension

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07879755) titled 'An Extension Trial of GW 906 in Participants With Essential Hypertension' on Sept. 18.

Brief Summary: This clinical study was designed to assess the safety and efficacy of long-term dosing of GW906

Study Start Date: June 12

Study Type: INTERVENTIONAL

Condition: Hypertension

Intervention: DRUG: GW906

Subcutaneous injection. Expected to be up to 2 years

Recruitment Status: RECRUITING

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Disclaimer: Curated by HT Syndication....